Covaxin trials in children between 2 and 18 years to begin in 10-12 days, says Niti Aayog member latest news and updates Trial of covaxin will begin in two weeks, vaccine will be given to 525 children aged 2 to 18 years

0
12
  • Hindi news
  • National
  • Covaxin Trials In Children Between 2 And 18 Years To Begin In 10 12 Days, Says Niti Aayog Member Latest News And Updates

Fed up with Ads? Install Dainik NewsBust India app for news without ads

New Delhi3 minutes ago

  • Copy link

There is good news amid fears that the third wave of Corona is said to be dangerous for children. The government has approved a trial of covaxin on children. NITI Aayog member Dr VK Paul said on Tuesday that the Drug Controller General of India (DCGI) has approved the second and third phase of clinical trials of Covaxin on children aged 2 to 18 years.

Dr. Paul said, ‘I have been told that these trials will begin in the next 10-12 days. In addition, DRDO’s developed anti-covid drug 2DG has also received emergency use approval. We will examine the drug to add it to the treatment protocol. ‘ Kovaxin is currently being used for 18+ vaccination in the country.

Trial will be held in Delhi, Patna and Nagpur
Subject Experts Committee has agreed to trial 525 children in AIIMS Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences Nagpur. After its success, after India and Canada, Corona’s indigenous vaccine will be ready for the age group of 2 to 18 years in India as well. Kovaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Data monitoring board will have to provide trial data for the second phase
According to sources, the Experts Committee has instructed the company to provide safety data of the second phase to the Data and Safety Monitoring Board (DSMB) before taking permission from CDSCO for the third phase trial. Earlier in the meeting held on 24 February, the proposal was discussed and Bharat Biotech was directed to introduce the Revised Clinical Trial Protocol.

Vaccine approved for 12 to 15-year-old teenagers in the US
Earlier on Monday, the US Food and Drug Administration (US-FDA) approved the Corona vaccine of Pfizer-BioNTecch for children between 12 and 15 years old. Till now this vaccine was being given to those above 16 years of age.

Children are currently allowed to apply the Corona vaccine in the US and Canada.

Children are currently allowed to apply the Corona vaccine in the US and Canada.

Canada has earlier approved this first child vaccine. He is the first country in the world to do so. It is believed that vaccination of children between 12 and 15 years will clear the way for the opening of large number of schools and summer camps in the US.

There are more news …

LEAVE A REPLY

Please enter your comment!
Please enter your name here